May 27, 2026 02:49PM
May 18, 2026 08:02AM
May 7, 2026 07:01AM
May 6, 2026 08:58AM
May 1, 2026 07:00AM
Mar 23, 2026 12:12PM
Mar 23, 2026 07:00AM Viatris receives Japan approval for Effexor to treat anxiety disorder
Mar 19, 2026 08:31AM
Mar 12, 2026 09:55AM
Feb 27, 2026 10:49AM
Feb 26, 2026 04:34PM
Feb 26, 2026 07:00AM
Feb 25, 2026 06:59AM
Feb 9, 2026 05:27AM UBS Upgrades Viatris (VTRS) to Buy
Feb 3, 2026 08:30AM
Jan 28, 2026 08:58AM
Jan 20, 2026 07:00AM
Jan 16, 2026 07:16AM
Jan 8, 2026 09:06AM
Dec 18, 2025 06:59AM
Dec 8, 2025 02:55AM Viatris to sell Biocon Biologics stake for $815 million
Nov 6, 2025 07:06AM
Oct 15, 2025 06:04AM
Aug 19, 2025 09:01AM
Aug 11, 2025 09:29AM
Aug 7, 2025 07:03AM
Aug 5, 2025 06:55AM
Jul 18, 2025 09:48AM Goldman Sachs Reiterates Neutral Rating on Viatris (VTRS)
Jun 30, 2025 04:42AM
Jun 26, 2025 06:55AM
Jun 6, 2025 03:30AM
Jun 3, 2025 10:18AM
Jun 3, 2025 07:36AM
Jun 2, 2025 01:28PM
Jun 2, 2025 08:00AM Viatris Inc (VTRS) Announces Positive Top-Line Results from Phase 3 LYNX-2 Trial of MR-142
Jun 1, 2025 09:15AM
Jun 1, 2025 06:18AM
May 31, 2025 12:14PM
May 30, 2025 12:08PM
May 30, 2025 10:40AM
May 30, 2025 07:36AM
May 29, 2025 04:00PM VTRS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Viatris Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
May 29, 2025 10:40AM
May 28, 2025 04:12PM
May 28, 2025 07:18AM
May 26, 2025 11:59PM
May 26, 2025 09:43AM
May 26, 2025 08:21AM
May 25, 2025 11:54PM VTRS DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Viatris Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important June 3 Deadline in Securities Class Acti
May 25, 2025 09:27AM

408,180 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All